Maternal oxygen administration for suspected impaired fetal growth

Citations of this article
Mendeley users who have this article in their library.
Get full text


Background: Fetal hypoxaemia is often a feature of fetal growth impairment. It has been suggested that perinatal outcome after suspected impaired fetal growth might be improved by giving mothers continuous oxygen until delivery. Objectives: The objective was to assess the effects of maternal oxygen therapy in suspected impaired fetal growth on fetal growth and perinatal outcome. Search strategy: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (June 2009). Selection criteria: Acceptably controlled trials comparing maternal oxygen therapy with no oxygen therapy in suspected impaired fetal growth. Data collection and analysis: Eligibility and trial quality was assessed. Main results : Three studies involving 94 women were included. Oxygenation compared with no oxygenation was associated with a lower perinatal mortality rate (risk ratio 0.50, 95% confidence interval 0.32 to 0.81). However, higher gestational age in the oxygenation groups may have accounted for the difference in mortality rates. Copyright © 2009 The Cochrane Collaboration. Published by JohnWiley & Sons, Ltd.




Say, L., Gülmezoglu, A. M., & Hofmeyr, G. J. (2009). Maternal oxygen administration for suspected impaired fetal growth. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free